(Q36302240)

English

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

scientific article

Statements

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials (English)
Jorge Sánchez-Guerrero
Sandra V Navarra
William Freimuth
BLISS-52 and BLISS-76 Study Groups

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit